Kymate 3

Kymate 3 is an antibiotic injection that consists of Colistimethate 3 MIU (Million International Units) as its active ingredient. Colistimethate sodium is a polymyxin antibiotic used by doctors for treating of a few specific bacterial infections caused by sensitive gram negative bacteria. It is usually reserved for conditions where other antibiotics may not offer a proper treatment option specifically when infections include bacteria with limited sensitivity to commonly used antibiotics.

Kymate 3 is given only by a qualified healthcare professional. The choice of giving this medicine to the patient is based on the type and intensity of the infection along with kidney function, vulnerability of the bacteria and the patient’s health condition.

Composition of Kymate 3

The active composition of Kymate 3 is Colistimethate Sodium

Uses of Kymate 3 Injection

Colistimethate sodium may be used for selected serious infections caused by susceptible Gram-negative bacteria. Depending on clinical assessment and local prescribing guidelines, it may be considered for infections involving organisms such as Pseudomonas aeruginosa and Acinetobacter species.

It may be used in the management of certain complicated infections affecting areas such as:

• Respiratory tract and lungs
• Urinary tract
• Bloodstream
• Other sites associated with serious Gram-negative bacterial infections

The exact use of Kymate 3 depends on microbiological test results, antibiotic susceptibility, and the treating physician’s clinical judgement. It should not be used for viral infections such as influenza or the common cold.

How Does Colistimethate Work?

Colistimethate sodium is a prodrug that is converted to colistin, its active antibacterial form. Colistin acts primarily on the outer membrane of susceptible Gram-negative bacteria. It interacts with components of the bacterial membrane, disrupting its structure and increasing membrane permeability.

This disruption can cause leakage of important cellular contents and ultimately leads to bacterial cell death. Because of its activity against certain multidrug-resistant Gram-negative organisms, colistimethate may be reserved for serious infections where alternative antibiotics are unsuitable.

Dosage and Administration

Kymate 3 should only be administered by a qualified healthcare professional. The dosage and duration depend on factors such as the severity and location of the infection, the susceptibility of the bacteria, the patient’s body weight, age, and kidney function.

Dose adjustment may be required in patients with impaired renal function. The injection should be prepared, diluted, and administered according to the approved product information and institutional protocols. Patients should never self-administer this medicine or alter the prescribed dose.

Safety Information and Precautions

Colistimethate requires careful medical supervision because it can cause important adverse effects, particularly involving the kidneys and nervous system. Healthcare professionals may monitor kidney function during treatment, especially in patients who are at increased risk of renal impairment.

Possible adverse effects can include kidney-related problems, weakness, dizziness, tingling or numbness, and other neurological symptoms. Allergic reactions may also occur. Patients should inform their doctor about existing kidney problems, neurological disorders, allergies, pregnancy, breastfeeding, and other medicines they are taking.

Storage and Handling

Kymate 3 should be stored and handled according to the manufacturer’s instructions on the product packaging. Reconstitution and administration should be performed by trained healthcare personnel using appropriate aseptic techniques.

Conclusion

Kymate 3 contains Colistimethate 3 MIU and is a specialised antibiotic option for selected serious Gram-negative bacterial infections. Its use should be guided by microbiological evidence, antibiotic susceptibility, renal function, and professional clinical judgement. Appropriate dosing, monitoring, and responsible antibiotic use are essential to help achieve effective treatment while reducing the risk of adverse effects and antimicrobial resistance.